VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 763 filers reported holding VANECK VECTORS ETF TR in Q1 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $53,690,000 | -75.5% | 1,400,000 | -79.3% | 0.07% | -74.8% |
| Q1 2021 | $219,463,000 | +43.1% | 6,752,712 | +58.6% | 0.29% | +24.9% |
| Q4 2020 | $153,348,000 | -79.4% | 4,257,300 | -77.6% | 0.23% | -83.7% |
| Q3 2020 | $744,040,000 | +42.3% | 19,000,000 | +33.3% | 1.40% | +25.6% |
| Q2 2020 | $522,690,000 | +5.6% | 14,250,000 | -15.7% | 1.12% | +14.8% |
| Q4 2019 | $494,832,000 | -11.8% | 16,900,000 | -19.5% | 0.97% | -15.8% |
| Q3 2019 | $560,910,000 | -23.0% | 21,000,000 | -26.3% | 1.16% | -21.5% |
| Q2 2019 | $728,460,000 | +52.5% | 28,500,000 | +33.8% | 1.47% | +59.8% |
| Q1 2019 | $477,546,000 | -16.4% | 21,300,000 | -21.4% | 0.92% | -27.7% |
| Q4 2018 | $571,491,000 | +33.0% | 27,100,000 | +16.8% | 1.27% | +60.3% |
| Q3 2018 | $429,664,000 | +105.4% | 23,200,000 | +132.0% | 0.79% | +4.6% |
| Q4 2016 | $209,200,000 | – | 10,000,000 | – | 0.76% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
| New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
| TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
| Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
| Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
| New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
| Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
| Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
| STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
| PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |